Preliminary net sales included $25.9M related to the previously disclosed December 2024 ICL shipment that was subject to extended payment terms, and which was paid in full during the third quarter 2025 pursuant to such payment terms. The year over year increase in preliminary net sales was primarily driven by the December China Shipment combined with 7.7% growth in net sales outside China, partially offset by lower new orders from distributors in China during the third quarter 2025, due in part to leaner inventory management during the quarter.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Broadwood urges shareholders vote ‘AGAINST’ acquisition of STAAR by Alcon
- Staar Surgical says no acquisition proposals received except from Alcon
- Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale
- STAAR Surgical Faces Legal Challenges in Alcon Merger
- Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale